| | | | |
CUSIP No. 98985X100 | | Schedule 13G | | Page 5 of 8 |
ITEM 1. | (a) Name of Issuer: |
Zymergen Inc. (the “Issuer”).
| (b) | Address of Issuer’s Principal Executive Offices: |
5959 Horton Street, Suite 700, Emeryville, California 94608
ITEM 2. | (a) Name of Person Filing: |
Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:
SB Investment Advisers (UK) Limited (“SBIA UK”)
SoftBank Vision Fund (AIV M1) L.P. (“AIV M1”)
SVF Endurance (Cayman) Limited
SVF Excalibur (Cayman) Limited
| (b) | Address or Principal Business Office: |
The address for SBIA UK is 69 Grosvenor Street, London W1K 3JP, United Kingdom. The address for AIV M1 is 251 Little Falls Drive, Wilmington, Delaware 19808. The address for each of SVF Excalibur (Cayman) Limited and SVF Endurance (Cayman) Limited is c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands.
| (c) | Citizenship of each Reporting Person is: |
SBIA UK is organized under the laws of England and Wales. AIV M1 is organized under the laws of the State of Delaware. Each of SVF Excalibur (Cayman) Limited and SVF Endurance (Cayman) Limited is organized under the laws of the Cayman Islands.
| (d) | Title of Class of Securities: |
Common Stock, par value $0.001 per share (“Common Stock”).
98985X100
Not applicable.